Perbedaan Intiland Development Tbk. dan Cipta Sarana Medika Tbk.: Intiland Development Tbk. diperdagangkan di Rp115 (kapitalisasi pasar 1,2 T, volume 24 jam 12,33 jt), sedangkan Cipta Sarana Medika Tbk. diperdagangkan di Rp63 (kapitalisasi pasar 158,12 M, volume 24 jam 8,21 jt). Perbedaan utamanya: Intiland Development Tbk. jauh lebih besar — sekitar 7,6× kapitalisasi pasar Cipta Sarana Medika Tbk., dan Intiland Development Tbk. lebih aktif diperdagangkan (12,33 jt vs 8,21 jt). Mana yang lebih baik tergantung tujuan investasimu.
| DILD | DKHH | |
|---|---|---|
Kapitalisasi Pasar | 1,2 T | 158,12 M |
Volume | 12,33 jt | 8,21 jt |
Lot | 123,31 rb | 82,15 rb |
Perputaran | 1,42 M | 515,2 jt |
Harga Rata-rata | 115,27 | 62,72 |
Nilai Transaksi | 1,42 M | 515,2 jt |
Harga Ekuilibrium Indikatif | 115 | 63 |
Volume Ekuilibrium Indikatif | 33 | 1,33 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Intiland Development Tbk formerly Dharmala Intiland, controlled by the Gondokusumo family, was established in 1983 as the property arm of the Dharmala Group. The company is basically a real estate developer with its principal asset being the 240-hectare Grande Family Estate in Surabaya.
Selengkapnya di halaman DILD →PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Selengkapnya di halaman DKHH →